
Keywords: فسفاتیدیلتانولامین; AD; Alzheimer's disease; DMPE; 1,2-dimyristoyl-sn-glycero-3-phosphoethanolamine; HDPs; host defence peptides; HIV; human immunodeficiency virus; IAPPs; islet amyloid polypeptides; LPS; lipopolysaccharide; MD; molecular dynamic; PE; phosphatidylethanolam